http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SV-2006002191-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D281-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 2005-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_460d0e62ed0278ff3ab6d67962333c08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bd89739cdda496a23d16600f8f0974f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5f9df09fb54817515c059b05cc36d62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a861ef15b8014ccad2279a882a723f97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4afac31615ee56c98315a73e1117c9a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_428512b9b8c26e9b5c3eb3a196d2c027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9050ee69002dd7b4c8a8b0825d016cac
publicationDate 2006-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SV-2006002191-A
titleOfInvention DERIVATIVES OF ACETIC ACID WITH CICLOHEXILMETOXI SUBSTITUTES, PROCEDURE FOR PREPARATION AND USE AS A MEDICINAL PRODUCT
abstract DERIVATIVES OF ACETIC ACID WITH CICLOHEXILMETOXI SUBSTITUTES, PROCEDURE FOR ITS PREPARATION AND ITS USE AS MEDICATIONS. THE INVENTION REFERS TO ACETIC ACID DERIVATIVES WITH CICLOHEXILMETOXI SUBSTITUENTS AND PHYSIOLOGICALLY TOLERATED SALTS AND PHYSIOLOGICALLY FUNCTIONAL DERIVATIVES OF THE SAME. COMPOSITE OF FORMULA I (SEE FORMULA) IN WHICH THE RADICALS HAVE THE MEANINGS THAT ARE INDICATED, AND THE PHYSIOLOGICALLY TOLERATED SALTS OF THE SAME, AND THE PROCEDURES TO PREPARE THEM HAVE BEEN DESCRIBED. THE COMPOUNDS ARE ADEQUATE, FOR EXAMPLE, TO TREAT AND / OR PREVENT DISORDERS IN WHICH INSULIN RESISTANCE IS INVOLVED
priorityDate 2004-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350

Total number of triples: 26.